Correlation Between Clal Biotechnology and Brainsway

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Brainsway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Brainsway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Brainsway, you can compare the effects of market volatilities on Clal Biotechnology and Brainsway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Brainsway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Brainsway.

Diversification Opportunities for Clal Biotechnology and Brainsway

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Clal and Brainsway is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Brainsway in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainsway and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Brainsway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainsway has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Brainsway go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Brainsway

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Brainsway. In addition to that, Clal Biotechnology is 1.14 times more volatile than Brainsway. It trades about -0.02 of its total potential returns per unit of risk. Brainsway is currently generating about 0.15 per unit of volatility. If you would invest  40,270  in Brainsway on August 31, 2024 and sell it today you would earn a total of  135,830  from holding Brainsway or generate 337.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Brainsway

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Brainsway 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Brainsway sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Brainsway Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Brainsway

The main advantage of trading using opposite Clal Biotechnology and Brainsway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Brainsway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will offset losses from the drop in Brainsway's long position.
The idea behind Clal Biotechnology Industries and Brainsway pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device